22 PERSISTENT OPIOID USE AND HEALTHCARE UTILIZATION AMONG ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES

2018 ◽  
Vol 154 (1) ◽  
pp. S46
Author(s):  
Anava Wren ◽  
Rachel Bensen ◽  
Lindsay Sceats ◽  
Helen Yu ◽  
Jessie Wong ◽  
...  
Keyword(s):  
United States ◽  
Inflammatory Bowel Disease ◽  
Young Adults ◽  
Healthcare Utilization ◽  
Bowel Disease ◽  
The United States ◽  
Adolescents And Young Adults ◽  
Opioid Use ◽  
Inflammatory Bowel

scholarly journals Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015

2018 ◽  
Vol 24 (10) ◽  
pp. 2093-2103 ◽  
Author(s):  
Anava A Wren ◽  
Rachel Bensen ◽  
Lindsay Sceats ◽  
Melody Dehghan ◽  
Helen Yu ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Young Adults ◽  
Bowel Disease ◽  
The United States ◽  
Opioid Therapy ◽  
Vulnerable Population ◽  
Adolescents And Young Adults ◽  
Opioid Use ◽  
Chronic Opioid Therapy ◽  
Inflammatory Bowel

Abstract Background Opioids are commonly prescribed for relief in inflammatory bowel disease (IBD). Emerging evidence suggests that adolescents and young adults are a vulnerable population at particular risk of becoming chronic opioid users and experiencing adverse effects. Objectives This study evaluates trends in the prevalence and persistence of chronic opioid therapy in adolescents and young adults with IBD in the United States. Method A longitudinal retrospective cohort analysis was conducted with the Truven MarketScan Database from 2007 to 2015. Study subjects were 15–29 years old with ≥2 IBD diagnoses (Crohn’s: 555/K50; ulcerative colitis: 556/K51). Opioid therapy was identified with prescription claims within the Truven therapeutic class 60: opioid agonists. Persistence of opioid use was evaluated by survival analysis for patients who remained in the database for at least 3 years following index chronic opioid therapy use. Results In a cohort containing 93,668 patients, 18.2% received chronic opioid therapy. The annual prevalence of chronic opioid therapy increased from 9.3% in 2007 to 10.8% in 2015 (P < 0.01), peaking at 12.2% in 2011. Opioid prescriptions per patient per year were stable (approximately 5). Post hoc Poisson regression analyses demonstrated that the number of opioid pills dispensed per year increased with age and was higher among males. Among the 2503 patients receiving chronic opioid therapy and followed longitudinally, 30.5% were maintained on chronic opioid therapy for 2 years, and 5.3% for all 4 years. Conclusion Sustained chronic opioid use in adolescents and young adults with IBD is increasingly common, underscoring the need for screening and intervention for this vulnerable population.

P140 CURRENT STATUS OF HOME INFUSIONS FOR INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES

2018 ◽  
Vol 154 (1) ◽  
pp. S72-S73 ◽  
Author(s):  
Bharati Kochar ◽  
Yue Jiang ◽  
Christopher F. Martin ◽  
Edward L. Barnes ◽  
Millie D. Long
Keyword(s):  
United States ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
The United States ◽  
Current Status ◽  
Inflammatory Bowel

scholarly journals In-hospital outcomes of inflammatory bowel disease in cannabis users: a nationwide propensity-matched analysis in the United States

2019 ◽  
Vol 7 (12) ◽  
pp. 252-252 ◽  
Author(s):  
Rupak Desai ◽  
Upenkumar Patel ◽  
Hemant Goyal ◽  
Afrina Hossain Rimu ◽  
Dipen Zalavadia ◽  
...  
Keyword(s):  
United States ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
The United States ◽  
Hospital Outcomes ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document